Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Gary L Crocker. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Gary L Crocker har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MACK / Merrimack Pharmaceuticals, Inc. See Remarks, Director 133.105
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Gary L Crocker. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Gary L Crocker som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-08-14 2023-08-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 133.105 1,53 12,43 24.865 1.654.841
2023-08-14 2023-08-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 133.105 1,53 12,52 25.039 1.666.421
2022-06-13 2022-06-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.452 131.105 3,52 5,15 22.918 674.902
2022-06-09 2022-06-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 349 126.653 0,28 5,14 1.795 651.452
2022-06-09 2022-06-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 126.304 0,24 5,05 1.515 637.835
2022-05-26 2022-05-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 132 126.004 0,10 5,13 678 647.005
2022-05-26 2022-05-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.323 125.872 1,88 5,09 11.817 640.298
2022-05-23 2022-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 512 123.549 0,42 5,04 2.582 623.033
2022-05-19 2022-05-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 123.037 4,24 5,08 25.407 625.200
2022-05-19 2022-05-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 225 118.037 0,19 5,10 1.147 601.469
2022-05-16 2022-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3 117.812 0,00 4,90 15 577.279
2022-05-16 2022-05-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.471 117.809 2,14 5,04 12.456 593.863
2022-04-25 2022-04-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 115.338 4,53 6,00 30.001 692.051
2022-04-01 2022-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 110.338 0,27 6,18 1.853 681.525
2022-04-01 2022-03-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 161 110.038 0,15 6,20 998 682.236
2022-03-29 2022-03-28 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 109.877 4,77 6,16 30.822 677.315
2022-03-24 2022-03-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 400 104.877 0,38 6,11 2.446 641.197
2022-03-17 2022-03-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.649 104.477 4,66 6,14 28.556 641.729
2022-03-15 2022-03-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 99.828 5,27 6,02 30.120 601.374
2022-03-15 2022-03-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 94.828 5,57 6,08 30.406 576.678
2022-02-23 2022-02-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.351 89.828 3,88 5,96 19.970 535.312
2022-02-18 2022-02-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 86.477 6,14 6,13 30.626 529.689
2022-02-18 2022-02-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.945 81.477 10,80 6,20 49.231 504.872
2022-02-16 2022-02-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 123 73.532 0,17 6,20 763 455.898
2022-02-16 2022-02-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.800 73.409 2,51 5,96 10.724 437.341
2022-01-31 2022-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 673 71.609 0,95 4,60 3.096 329.401
2022-01-27 2022-01-26 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.100 70.936 4,57 4,56 14.121 323.128
2022-01-25 2022-01-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.105 67.836 11,70 4,33 30.741 293.506
2022-01-25 2022-01-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 60.731 3,41 4,65 9.310 282.691
2022-01-20 2022-01-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 58.731 9,31 4,54 22.690 266.515
2022-01-18 2022-01-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 53.731 10,26 4,51 22.554 242.364
2022-01-18 2022-01-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 48.731 11,43 4,42 22.120 215.591
2022-01-13 2022-01-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 43.731 12,91 4,33 21.658 189.425
2022-01-13 2022-01-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 38.731 14,82 4,03 20.140 156.012
2021-06-14 2021-06-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2021-04-14 2021-04-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 973 33.731 2,97 6,07 5.905 204.713
2021-04-12 2021-04-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.200 32.758 3,80 6,10 7.320 199.824
2021-04-09 2021-04-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2.127 31.558 7,23 6,19 13.166 195.344
2021-04-01 2021-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 500 29.431 1,73 6,19 3.094 182.148
2021-03-26 2021-03-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 200 28.931 0,70 6,13 1.226 177.347
2021-03-25 2021-03-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 28.731 21,07 6,34 31.690 182.097
2021-03-25 2021-03-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.627 23.731 18,04 6,47 23.455 153.461
2021-03-17 2021-03-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 20.104 33,10 6,79 33.956 136.530
2021-03-05 2021-02-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 15.104 49,49 7,20 36.004 108.762
2021-02-17 2021-02-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 10.104 97,96 7,47 37.342 75.461
2021-02-12 2021-02-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1.604 5.104 45,83 7,98 12.798 40.722
2021-02-12 2021-02-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.500 3.500 7,64 26.757 26.757
2020-08-03 2020-07-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -6.228 0 -100,00 3,20 -19.942
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17.250 0 -100,00 3,20 -55.234
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -52.068 0 -100,00 3,04 -158.386
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -86.549 0 -100,00 3,04 -263.273
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -8.428 0 -100,00 3,20 -26.986
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -5.986 0 -100,00 3,04 -18.209
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17.000 0 -100,00 3,20 -54.434
2019-10-21 2019-10-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2018-06-15 2018-06-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.000 8.000
2017-09-15 2017-09-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8.625 8.625
2016-06-16 2016-06-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 49.500 49.500
2015-05-18 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 17.500 17.500
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50.000 0 -100,00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35.000 0 -100,00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50.000 2.943.961 1,73 2,47 123.500 7.271.584
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35.000 2.893.961 1,22 1,71 59.850 4.948.673
2014-11-14 2014-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8.630 2.858.961 0,30 8,37 72.233 23.929.504
2014-11-14 2014-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5.760 2.850.331 0,20 8,62 49.651 24.569.853
2014-06-24 2014-06-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36.000 2.844.571 1,28 6,84 246.240 19.456.866
2014-05-22 2014-05-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.000 2.808.571 0,14 6,69 26.760 18.789.340
2014-05-20 2014-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6.000 2.804.571 0,21 6,71 40.260 18.818.671
2014-05-20 2014-05-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3.400 2.798.571 0,12 6,63 22.542 18.554.526
2014-05-15 2014-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37.834 37.834
2014-05-08 2014-05-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4.400 2.795.171 0,16 6,77 29.788 18.923.308
2014-05-07 2014-05-06 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7.500 2.790.771 0,27 6,85 51.375 19.116.781
2014-05-07 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 2.783.271 0,36 6,92 69.200 19.260.235
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35.000 0 -100,00
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35.000 2.773.271 1,28 1,25 43.750 3.466.589
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 2.738.271 0,37 6,69 66.900 18.319.033
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50.000 0 -100,00
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50.000 2.728.271 1,87 1,25 62.500 3.410.339
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.678.271 2,64 3,74 257.998 10.014.323
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.609.271 2,72 3,71 255.755 9.671.524
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69.000 2.540.271 2,79 3,71 255.783 9.416.785
2013-06-13 2013-06-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37.834 37.834
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15.015 2.471.271 0,61
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15.015 2.456.256 0,62
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -90.090 2.441.241 -3,56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 39.000 2.531.331 1,56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -39.000 2.492.331 -1,54
2012-12-17 2012-12-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36.500 2.531.331 1,46 6,77 247.214 17.144.705
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25.800 2.494.831 1,04 8,34 215.172 20.806.891
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 39.000 2.469.031 1,60 8,32 324.437 20.539.622
2012-08-27 2012-08-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 31.600 31.600
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -450.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23.300 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23.300 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28.332 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28.332 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21.429 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21.429 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -35.714 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -184.975 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -300.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -30.000 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -15.863 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -313.266 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -41.900 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -46.676 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -463.654 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -59.863 0 -100,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 450.000 2.430.031 22,73
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22.000 1.980.031 1,12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22.000 1.980.031 1,12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23.300 1.958.031 1,20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23.300 1.958.031 1,20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28.332 1.934.731 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28.332 1.934.731 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21.429 1.906.399 1,14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21.429 1.906.399 1,14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79.000 1.884.970 4,37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79.000 1.884.970 4,37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 35.714 1.631.909 2,24
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 184.975 1.596.195 13,11
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 300.000 1.411.220 27,00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 30.000 1.111.220 2,77
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 15.863 1.081.220 1,49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 313.266 1.065.357 41,65
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 41.900 752.091 5,90
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 46.676 710.191 7,03
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 463.654 663.515 231,99
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 59.863 199.861 42,76
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25.000 139.998 21,74 7,00 175.000 979.986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 21.428 114.998 22,90 7,00 149.996 804.986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 14.285 93.570 18,02 7,00 99.995 654.990
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 15.000 79.285 23,33 7,00 105.000 554.995
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 64.285 64.285 7,00 449.995 449.995
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)